Sharon Barbari's Net Worth

$3.26 Million

Estimate Recalculated Apr 25, 2024 05:56PM EST

Who is Sharon Barbari?

Sharon Barbari has an estimated net worth of $3.26 Million. This is based on reported shares across multiple companies, which include CYTOKINETICS INC, Foamix Pharmaceuticals Ltd., VYNE Therapeutics Inc., AGILE THERAPEUTICS INC, Sonoma Pharmaceuticals, Inc., and INTERMUNE INC.

SEC CIK

Sharon Barbari's CIK is 0001240499

Past Insider Trading and Trends

2016 was Sharon Barbari's most active year for acquiring shares with 7 total transactions. Sharon Barbari's most active month to acquire stocks was the month of January. 2012 was Sharon Barbari's most active year for disposing of shares, totalling 2 transactions. Sharon Barbari's most active month to dispose stocks was the month of August. 2004 saw Sharon Barbari paying a total of $8,554.40 for 110,680 shares, this is the most they've acquired in one year. In 2017 Sharon Barbari cashed out on 7,317 shares for a total of $77,560.20, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

CYTOKINETICS INC (CYTK) Snapshot price: $77.2

EVP, Finance & CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+39.57%
11.43K
$10.60
-$77,541.45
40.32K
Feb 28
Form 4
—
0
—
—
0
Feb 23
Form 4
—
0
—
—
0
Feb 26
Form 4
—
0
—
—
0
Feb 24
Form 4
+72.38%
10.4K
$7.65
-$47,904.30
24.78K
Sep 3
Form 4
—
0
—
—
0
Mar 5
Form 4
+310.98%
63.37K
$0.76
-$27,832.23
83.75K
Sep 4
Form 4
—
0
—
—
0
Mar 5
Form 4
—
0
—
—
0
Nov 17
Form 4
—
0
—
—
0
Feb 28
Form 4
—
0
—
—
0
Feb 24
Form 4
+16.49%
2K
$3.37
$6,740.00
14.13K
Nov 16
Form 4
—
0
—
—
0
Feb 26
Form 4
—
0
—
—
0
Feb 29
Form 4
—
0
—
—
0
Mar 14
Form 4
—
0
—
—
0
Mar 1
Form 4
—
0
—
—
0
Apr 11
Form 4
—
0
—
—
0
Sep 15
Form 3
—
0
—
—
0
No matching records found

Foamix Pharmaceuticals Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 9
Form 4
—
0
—
—
0
May 16
Form 3
—
0
—
—
0
No matching records found

VYNE Therapeutics Inc. (VYNE) Snapshot price: $2.19

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Dec 13
Form 4
—
0
—
—
0
Aug 10
Form 3
—
0
—
—
0
No matching records found

AGILE THERAPEUTICS INC (AGRX) Snapshot price: $1.3299

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2,397.44%
935
—
—
974
Jun 8
Form 4
+52.26%
670
—
—
1.95K
Jun 9
Form 4
+91.50%
24.51K
—
—
51.3K
Jun 8
Form 4
∞
26.79K
—
—
26.79K
Jun 9
Form 3
—
0
—
—
0
No matching records found

Sonoma Pharmaceuticals, Inc. (SNOA) Snapshot price: $0.16

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3.39%
1.42K
—
—
43.42K
Mar 1
Form 4
+69.45%
17.21K
—
—
41.99K
Jan 2
Form 4
+128.66%
13.94K
—
—
24.78K
Nov 29
Form 4
+8.84%
880
—
—
10.84K
Aug 29
Form 4
+8.19%
754
—
—
9.96K
May 30
Form 4
+47.41%
2.96K
—
—
9.2K
Feb 28 - Mar 1
Form 4
+19.87%
1.03K
—
—
6.24K
Nov 29
Form 4
+29.90%
1.2K
—
—
5.21K
Aug 29
Form 4
+28.48%
4.45K
—
—
20.05K
May 31
Form 4
∞
15.61K
—
—
15.61K
Feb 29
Form 4
—
0
—
—
0
Nov 30
Form 4
—
0
—
—
0
Aug 31
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Dec 1
Form 4
—
0
—
—
0
Jul 15
Form 3
—
0
—
—
0
No matching records found